Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Meloxicam launched in Great Britain

Sep. 27, 1996

Development of COX-2 inhibitors at Searle

Sep. 27, 1996

Anika receives European marketing approval for osteoarthritis product

Sep. 27, 1996

U.S. patent covers hemopoietic regulator with potential in rheumatoid arthritis

Sep. 27, 1996

Monoclonal antibody effective in rheumatoid arthritis

Sep. 20, 1996

University of Kentucky's PC-16 for arthritis

Sep. 20, 1996

Progress in arthritis at Toyama

Sep. 13, 1996

Dual TNF production and PDE IV inhibitor from Pfizer

Sep. 13, 1996

Inhibitors of cytokine production reported by SmithKline Beecham

Sep. 13, 1996

Procter & Gamble discloses new matrix metalloproteinase inhibitors

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 4, 2025.
Biopharma exempt from US reciprocal tariffs, but not untouched
BioWorld
At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...
ADPD 2025: Unlocking GLP-1's potential in neurodegeneration
BioWorld
At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk A/S, who has extensive experience in...
Checkpoint inhibitor journey traces Chinese firms’ path to global revenue
BioWorld
Chinese pharmaceutical companies are making significant inroads into the global oncology market, particularly with the development and approval of immune...